HIV is a serious, lifelong infection, but how bad it is depends almost entirely on whether you get treated. Without treatment, HIV progresses to AIDS within about 10 years and is fatal. With modern treatment, most people live into their 70s or beyond and can’t pass the virus to others. That’s an enormous gap, and it’s worth understanding both sides of it.
What Happens Without Treatment
HIV attacks immune cells, specifically the white blood cells your body relies on to fight infections. Left alone, the virus slowly destroys these cells over a period that typically spans about a decade. During most of that time, you may feel completely fine, which is part of what makes HIV dangerous. The virus is quietly replicating and weakening your immune system even when you have no symptoms.
Once your immune cell count drops low enough, you’ve progressed to AIDS. At that point, your body can’t defend itself against infections and cancers that a healthy immune system would handle easily. Things like certain types of pneumonia, fungal infections, and rare cancers become life-threatening. Without treatment, people with AIDS typically survive about 3 years. Some progress faster than others, but the trajectory without medication is consistently downward.
What Treatment Changes
Modern HIV treatment, called antiretroviral therapy, works by blocking the virus from copying itself inside your cells. You take one pill a day (in most cases), and within a few months, the amount of virus in your blood drops so low that standard lab tests can’t detect it. This is called an undetectable viral load, defined as fewer than 200 copies of the virus per milliliter of blood.
Getting to undetectable does two critical things. First, it stops the virus from destroying your immune system, which means you don’t progress to AIDS. Second, and this surprises many people, it means you can’t transmit HIV to sexual partners. A major study tracking 888 couples where one partner was HIV-positive and on treatment found zero transmissions over more than 1,200 couple-years of follow-up. Zero. This is the basis of the public health message “undetectable equals untransmittable,” or U=U.
Treatment needs to be taken consistently and continued for life. Missing doses allows the virus to rebound, and inconsistent use can lead to drug resistance. But for people who take their medication as prescribed, the results are remarkable.
Life Expectancy Today
A 40-year-old man starting treatment today can expect to live about 37 more years, reaching his late 70s. A 40-year-old woman on treatment can expect about 39 more years. For comparison, in the general population those figures are roughly 41 and 46 years, respectively. That’s a gap of only 3 to 7 years, and it continues to shrink as treatments improve.
The gap narrows even further for people who start treatment early, before the virus has done significant immune damage. Women who began treatment with relatively healthy immune systems had a life expectancy only about 4 years shorter than average, according to a large collaborative study published in The Lancet HIV. For people diagnosed and treated early, HIV has shifted from a death sentence to a manageable chronic condition, closer in severity to something like well-controlled diabetes than to what the epidemic looked like in the 1980s and 1990s.
Long-Term Health Risks That Remain
Even with successful treatment, HIV isn’t consequence-free. The virus causes chronic, low-grade inflammation throughout the body that persists even when the viral load is undetectable. This ongoing inflammation takes a measurable toll over decades. People living with HIV have roughly 1.5 to 2 times the risk of developing heart disease compared to people without HIV. They may also be up to 4.5 times more likely to die from sudden cardiac death.
This elevated cardiovascular risk exists even in people whose virus is fully suppressed. The inflammation also appears to accelerate other age-related problems, including kidney disease, bone loss, and certain cancers. In practical terms, this means people with HIV often need earlier and more proactive screening for conditions that the general population typically encounters later in life. It also means that lifestyle factors like smoking, diet, and exercise matter even more when you’re living with HIV, because you’re working against an already elevated baseline of inflammation.
How HIV Spreads
HIV is not easy to catch through casual contact. It cannot spread through hugging, sharing food, using the same toilet, or breathing the same air. Transmission requires specific bodily fluids (blood, semen, vaginal fluid, or breast milk) to enter your body.
Even through the highest-risk activities, per-act transmission rates are lower than most people assume. For someone having unprotected receptive anal sex with an HIV-positive partner who is not on treatment, the risk is about 1 in 72 per act. For receptive vaginal sex, it’s about 1 in 1,250. For insertive vaginal sex, about 1 in 2,500. Sharing needles carries a higher risk. These numbers apply only when the HIV-positive person is not on treatment. When they are on treatment and undetectable, the risk drops to effectively zero.
Preventive medication called PrEP is also available for HIV-negative people at higher risk, reducing the chance of infection by about 99% when taken consistently.
The Global Picture
At the peak of the epidemic in 2004, about 2.1 million people died from AIDS-related causes worldwide in a single year. By 2024, that number had dropped to roughly 630,000, a 70% decline driven largely by expanded access to treatment. That’s enormous progress, but 630,000 deaths a year is still a staggering number, and most of those deaths happen in regions where treatment access remains limited. The severity of HIV in 2025 is inseparable from geography, healthcare access, and the ability to get diagnosed early.
The Practical Burden of Living With HIV
Beyond the biology, HIV carries a daily and financial reality. In the United States, the list price for most common one-pill-a-day regimens ranges from about $2,800 to $4,700 per month. Generic options exist for as low as $82 to $252 monthly, but they use older drug combinations. Most people don’t pay full list price thanks to insurance, manufacturer assistance programs, and government programs like the AIDS Drug Assistance Program, but navigating that system is itself a burden. In many countries, treatment is provided free through public health programs.
Then there’s stigma, which remains one of the most persistent harms of HIV. Fear of disclosure affects relationships, employment, and mental health. Many people living with HIV report that the social and psychological weight of the diagnosis is harder to manage than the medical side. Depression and anxiety are significantly more common among people with HIV, partly driven by stigma and partly by the biological effects of chronic inflammation on the brain.
So how bad is HIV? It is a serious, incurable virus that requires lifelong treatment and carries real long-term health risks. But with early diagnosis and consistent treatment, it is no longer the crisis it once was for most individuals who have access to care. The gap between treated and untreated HIV is one of the starkest in modern medicine.